Cardlytics (CDLX) stock price, revenue, and financials

Cardlytics market cap is $2 b, and annual revenue was $186.89 m in FY 2020

$2 B

CDLX Mkt cap, 24-Jan-2022

$65 M

Cardlytics Revenue Q3, 2021
Cardlytics Gross profit (Q3, 2021)24.5 M
Cardlytics Gross profit margin (Q3, 2021), %37.7%
Cardlytics Net income (Q3, 2021)-44.5 M
Cardlytics EBIT (Q3, 2021)-39.8 M
Cardlytics Cash, 30-Sept-2021237.4 M
Cardlytics EV2 B
Get notified regarding key financial metrics and revenue changes at CardlyticsLearn more
Banner background

Cardlytics Revenue

Cardlytics revenue was $186.89 m in FY, 2020 which is a 11.2% year over year decrease from the previous period.

Embed Graph

Cardlytics Revenue Breakdown

Embed Graph

Cardlytics revenue breakdown by business segment: 100.0% from Cardlytics Direct and 0.0% from Other

Cardlytics revenue breakdown by geographic segment: 87.3% from United States and 12.7% from United Kingdom

Cardlytics Income Statement

Annual

USDFY, 2018FY, 2019FY, 2020

Revenue

150.7m210.4m186.9m

Revenue growth, %

16%40%(11%)

Cost of goods sold

96.0m131.0m123.6m

Gross profit

54.7m79.5m63.3m

Gross profit Margin, %

36%38%34%

Sales and marketing expense

41.9m43.8m45.3m

R&D expense

16.2m11.7m17.5m

General and administrative expense

34.2m36.7m46.5m

Operating expense total

95.6m96.8m117.2m

Depreciation and amortization

3.3m4.5m7.8m

EBIT

(40.9m)(17.3m)(53.9m)

EBIT margin, %

(27%)(8%)(29%)

Interest expense

3.3m548.0k3.0m

Pre tax profit

(53.0m)(17.1m)(55.4m)

Net Income

(53.0m)(17.1m)(55.4m)

EPS

(2.8)(0.7)(2.0)

Cardlytics Balance Sheet

Annual

USDFY, 2018FY, 2019FY, 2020

Cash

39.6m104.5m293.2m

Accounts Receivable

58.1m81.5m81.2m

Prepaid Expenses

4.0m5.8m5.7m

Current Assets

4.0m195.7m385.6m

PP&E

10.2m14.3m13.9m

Total Assets

153.8m224.3m422.5m

Accounts Payable

2.1m1.2m1.4m

Short-term debt

21.0k24.0k4.7m

Current Liabilities

51.9m78.4m81.3m

Long-term debt

46.7m13.0k184.1m

Total Debt

46.7m37.0k188.8m

Total Liabilities

101.8m81.0m265.3m

Common Stock

7.0k8.0k8.0k

Additional Paid-in Capital

371.5m480.6m551.4m

Retained Earnings

(321.5m)(338.6m)(394.1m)

Total Equity

52.0m143.3m157.2m

Debt to Equity Ratio

0.9 x0 x1.2 x

Debt to Assets Ratio

0.3 x0 x0.4 x

Financial Leverage

3 x1.6 x2.7 x

Cardlytics Cash Flow

Annual

USDFY, 2018FY, 2019FY, 2020

Net Income

(53.0m)(17.1m)(55.4m)

Depreciation and Amortization

3.3m4.5m7.8m

Accounts Receivable

(9.4m)(26.0m)(2.4m)

Accounts Payable

911.0k(601.0k)16.0k

Cash From Operating Activities

(19.0m)11.5m(7.6m)

Purchases of PP&E

(5.9m)(8.3m)(5.4m)

Cash From Investing Activities

(7.3m)(11.0m)(10.1m)

Long-term Borrowings

(52.6m)(46.7m)223.1m

Cash From Financing Activities

65.2m44.2m206.4m

Net Change in Cash

38.6m44.7m188.8m

Interest Paid

1.3m63.0k

Cardlytics Ratios

USDFY, 2018

EV/EBIT

-6.1 x

EV/CFO

-13.2 x

Revenue/Employee

395.8k

Debt/Equity

0.9 x

Debt/Assets

0.3 x

Financial Leverage

3 x

P/E Ratio

(3.9)

Cardlytics Operating Metrics

Cardlytics's Monthly Active Users was reported to be 140.8 m in Q1, 2020.
FY, 2017Feb, 2018Q1, 2018Q2, 2018Q3, 2018FY, 2018Q1, 2019Q2, 2019Q3, 2019FY, 2019Q1, 2020

Monthly Active Users

54.94 m58.68 m58.81 m59.33 m65.01 m108.47 m120.13 m128.32 m122.59 m140.78 m

ARPU

$2.23$0.55$0.6$0.58$2.3$0.33$0.4$0.44$1.72$0.32

Online and In-store Transactions Analyzed

20 b35 b

U.S. Accounts Analyzed

100 m175 m

Patents Issued

3444444444

Patents Pending

1046555551010

Clients

2.04 k

Cardlytics Employee Rating

3.3139 votes
Culture & Values
3.6
Work/Life Balance
3.5
Senior Management
2.9
Salary & Benefits
3.3
Career Opportunities
3.1
Source